1. Biologics in perspective: the case for generic biologic drugs Publication: Washington, D.C. : AARP Public Policy Institute, c2009 Subject(s): Biological Products -- economicsDrug ApprovalDrugs, Generic -- economicsChemistry, Pharmaceutical -- economicsDrug CostsEconomics, PharmaceuticalHealth ExpendituresPatents as TopicHumansUnited States
